肺液补充C1q的诊断准确性,用于老年患者结核性肺输液的诊断
Wen Zhao1, Yan Niu2, Jian-Xun Wen2
1Department of Laboratory Medicine, the Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China; Key Laboratory for Biomarkers, Inner Mongolia Medical University, Hohhot, China.
Cytokine
|October 12, 2024
概括
肺液中的补充C1q显示,对于老年患者的结核性肺输液 (TPE) 的诊断准确性有限. 需要进一步的研究来改善TPE在这个人群中的诊断.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 临床诊断 临床诊断 临床诊断
背景情况:
- 之前的研究表明,肺液C1q有助于诊断结核性肺溢液 (TPE).
- 然而,这些研究集中在年轻人群中,老年患者的诊断准确性尚不清楚.
- 本研究涉及C1q对TPE的诊断效用,特别是在老年人队列中.
研究的目的:
- 为了调查补充C1q在多液中的诊断准确性,以识别老年患者的结核性多溢液 (TPE).
- 评估C1q作为老年人群中TPE生物标志物的有效性.
主要方法:
- 预期招募患有未被诊断的多发性溢血的患者.
- 在多液中测量C1q水平.
- 使用接收器操作特征 (ROC) 曲线分析进行诊断准确性评估.
主要成果:
- 该研究包括被诊断患有TPE (平均年龄75岁) 和非TPE (平均年龄71岁) 的老年患者.
- 与非TPE患者相比,TPE患者的肺液C1q水平显著更高.
- 对于C1q,ROC曲线下的面积 (AUC) 为0.67,表明诊断准确性较低. 在100 mg/L的值下,灵敏度为0.44和特异性为0.79.
结论:
- 肺液C1q在老年人中表现出结核性肺溢液 (TPE) 的诊断准确性较低.
- 单独的C1q可能不是诊断TPE的可靠生物标志物,在这个特定的人群中.
- 对老年人TPE的替代或组合诊断标志物的进一步研究是有必要的.
相关概念视频
01:30Pneumonia III: Complications and Assessment
181
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
181
01:26Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
01:28Pleural Effusion II: Symptoms and Management
155
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
155
01:31Pulmonary Tuberculosis III
307
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
307
01:25Pleural Effusion I: Introduction
654
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
654
01:29Pneumonia II: Pathophysiology
229
The pathophysiology of pneumonia involves the following steps:
229